Literature DB >> 9640127

Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis?

P S Helliwell1, P Hickling, V Wright.   

Abstract

OBJECTIVE: In 1971 McEwen and colleagues suggested that the radiological changes of classic ankylosing spondylitis (AS), and the changes of the spondylitis associated with inflammatory bowel disease differ in several respects from the radiological features of psoriatic and reactive spondylitis. The findings of this study have never been confirmed. The aim of this study was to replicate the McEwen study comparing films blinded to diagnostic group.
METHODS: The study population comprised 91 patients with classic AS, 15 patients with regional enteritis, 16 patients with ulcerative colitis, five patients with sexually acquired reactive arthritis, two with post-dysenteric arthritis, and 34 with psoriatic arthritis. Blinded reading of spinal radiographs was undertaken, scoring for severity, symmetry, paravertebral ossification, size of syndesmophytes, ligamentous calcification, squaring, discitis, pseudofractures, zygoapophyseal joint involvement, and complete ankylosis.
RESULTS: Comparison of the four groups--classic, enteropathic, psoriatic, and reactive AS--showed differences with respect to symmetry of sacroiliitis, symmetry of lumbar spinal involvement, and frequency and size of syndesmophytes. Zygoapophyseal joint involvement was more frequent in the lumbar spine in classic and enteropathic spondylitis but no between group differences were found with respect to symphisitis, squaring, apophyseal joint involvement and ligamentous calcification in the lumbar spine, and other areas.
CONCLUSIONS: Some of the radiological differences described by McEwen et al, notably the asymmetry, the less severe changes, and the distinctive syndesmophytes in psoriasis, have been confirmed. A number of phypotheses are proposed to explain these differences including biomechanical, biochemical, and genetic factors.

Entities:  

Mesh:

Year:  1998        PMID: 9640127      PMCID: PMC1752543          DOI: 10.1136/ard.57.3.135

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

1.  Association between ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis: reality or fiction?

Authors:  K de Vlam; H Mielants; E M Veys
Journal:  Clin Exp Rheumatol       Date:  1996 Jan-Feb       Impact factor: 4.473

Review 2.  Seronegative spondarthritides.

Authors:  P Helliwell; V Wright
Journal:  Baillieres Clin Rheumatol       Date:  1987-12

3.  Enthesopathy of rheumatoid and ankylosing spondylitis.

Authors:  J Ball
Journal:  Ann Rheum Dis       Date:  1971-05       Impact factor: 19.103

4.  Paravertebral ossification in psoriatic arthritis.

Authors:  E G Bywaters; A S Dixon
Journal:  Ann Rheum Dis       Date:  1965-07       Impact factor: 19.103

5.  Measurement of back movement.

Authors:  I F Macrae; V Wright
Journal:  Ann Rheum Dis       Date:  1969-11       Impact factor: 19.103

6.  Ankylosing spondylitis and spondylitis accompanying ulcerative colitis, regional enteritis, psoriasis and Reiter's disease. A comparative study.

Authors:  C McEwen; D DiTata; C Lingg; A Porini; A Good; T Rankin
Journal:  Arthritis Rheum       Date:  1971 May-Jun

7.  Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis.

Authors:  D D Gladman; B Brubacher; D Buskila; P Langevitz; V T Farewell
Journal:  Clin Invest Med       Date:  1993-02       Impact factor: 0.825

8.  Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis.

Authors:  H S Goie The; M M Steven; S M van der Linden; A Cats
Journal:  Br J Rheumatol       Date:  1985-08

9.  A re-evaluation of the osteoarticular manifestations of psoriasis.

Authors:  P Helliwell; A Marchesoni; M Peters; M Barker; V Wright
Journal:  Br J Rheumatol       Date:  1991-10

Review 10.  Psoriatic arthritis. Genetics and HLA antigens.

Authors:  C J Eastmond
Journal:  Baillieres Clin Rheumatol       Date:  1994-05
View more
  33 in total

1.  Dynamics of syndesmophyte growth in AS as measured by quantitative CT: heterogeneity within and among vertebral disc spaces.

Authors:  Sovira Tan; Jianhua Yao; John A Flynn; Lawrence Yao; Michael M Ward
Journal:  Rheumatology (Oxford)       Date:  2014-11-12       Impact factor: 7.580

Review 2.  Mechanisms of pathologic new bone formation.

Authors:  Kurt de Vlam; Rik J U Lories; Frank P Luyten
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 3.  Seronegative spondyloarthropathies: to lump or split?

Authors:  P Nash; P J Mease; J Braun; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 4.  [Imaging methods in rheumatology: imaging in psoriasis arthritis (PsA)].

Authors:  R Rau; S Wasserberg; M Backhaus; J Braun; E Edelmann; H Kellner; B Ostendorf; M Rudwaleit; D Sandrock; J Schalm; A Scherer; W Schmidt
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

Review 5.  Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases?

Authors:  D D Gladman
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

6.  Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients.

Authors:  Jennifer H Jang; Michael M Ward; Adam N Rucker; John D Reveille; John C Davis; Michael H Weisman; Thomas J Learch
Journal:  Radiology       Date:  2010-10-22       Impact factor: 11.105

7.  Assessment and treatment of psoriatic spondylitis.

Authors:  Peter Nash
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

Review 8.  Imaging of the sacroiliac joint involvement in seronegative spondylarthropathies.

Authors:  Giuseppe Guglielmi; Giacomo Scalzo; Alessia Cascavilla; Marina Carotti; Fausto Salaffi; Walter Grassi
Journal:  Clin Rheumatol       Date:  2009-06-13       Impact factor: 2.980

9.  Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis.

Authors:  Gamze Kılıç; Erkan Kılıç; Kemal Nas; Murat Karkucak; Erhan Çapkın; Abdullah Zübeyir Dağlı; Remzi Çevik; Salih Özgöçmen
Journal:  Clin Rheumatol       Date:  2014-07-02       Impact factor: 2.980

Review 10.  Treatment recommendations for psoriatic arthritis.

Authors:  C T Ritchlin; A Kavanaugh; D D Gladman; P J Mease; P Helliwell; W-H Boehncke; K de Vlam; D Fiorentino; O Fitzgerald; A B Gottlieb; N J McHugh; P Nash; A A Qureshi; E R Soriano; W J Taylor
Journal:  Ann Rheum Dis       Date:  2008-10-24       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.